Has Rajesh Bhagat received payments from drug or device companies?

Yes. Drug and device makers reported $1,959 in general payments to Rajesh Bhagat across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rajesh Bhagat did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rajesh Bhagat come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rajesh Bhagat

Pulmonary Disease · Jackson, MSNPI 1700814829

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pulmonary disease clinicians in MS, where the typical reported total is $4,861.

$1,959in general payments, 2019–2025

Across 61 payments — averaging $32.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$353
GSK$340
Inari Medical, Inc.$255
Actelion Pharmaceuticals US, Inc.$154
Sanofi$128
Intuitive Surgical$106
plus $622 from 16 others

What the payments were for

Food & beverage$1,959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	8	$353
GSK	10	$340
Inari Medical, Inc.	6	$255
Actelion Pharmaceuticals US, Inc.	6	$154
Sanofi	2	$128
Intuitive Surgical	2	$106
Johnson & Johnson(2 entities)	2	$102
Genentech USA, Inc.	3	$100
Pulmonx Corporation	4	$72
Regeneron Healthcare Solutions, Inc.	2	$52
Mallinckrodt Hospital Products Inc.	2	$44
Bayer	2	$40
Ambu Inc.	1	$33
Novartis	2	$29
Grifols USA, LLC	2	$29
Insmed, Inc.	1	$28
Vapotherm Inc	1	$25
Mallinckrodt Enterprises LLC	1	$19
Getinge USA Sales, LLC	1	$16
E.r. Squibb & Sons, L.L.C.	1	$12
AstraZeneca	1	$11
Pfizer	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,959 in reported general payments places this provider in the 30th percentile of 101 pulmonary disease providers in Mississippi.

See all pulmonary disease providers in Mississippi →

Other pulmonary disease in Jackson

Demondes HaynesJackson$809K
Michal SenitkoJackson$185K
Andrew WilhelmJackson$51K
Raymond PortisJackson$39K
George AbrahamJackson$23K
Maria RappaiJackson$20K
Arash SamarghandiJackson$19K
Kimberly DobbsJackson$14K
Rajesh PatelJackson$13K
Charles EvansJackson$12K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →